Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-13

Clinical Trial Update: Combination Methotrexate and Infliximab [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing methotrexate plus infliximab for ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infliximab (infliximab)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED